Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

121. Pregabalin for pain in fibromyalgia in adults. Full Text available with Trip Pro

Pregabalin for pain in fibromyalgia in adults. This review updates part of an earlier Cochrane review on 'Pregabalin for acute and chronic pain in adults' (Moore 2009), and considers only fibromyalgia pain.Antiepileptic drugs have been used in pain management since the 1960s. Pregabalin is an antiepileptic drug also used in management of chronic pain conditions, including fibromyalgia. Pain response with pregabalin is associated with major benefits for other symptoms, and improved quality (...) of life and function in people with chronic painful conditions.To assess the analgesic efficacy and adverse events of pregabalin for pain in fibromyalgia in adults, compared with placebo or any active comparator.We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE for randomised controlled trials from inception to May 2009 for the original review and to 16 March 2016 for this update. We also searched the reference lists of retrieved studies and reviews

2016 Cochrane Controlled trial quality: predicted high

122. Oxycodone for pain in fibromyalgia in adults. Full Text available with Trip Pro

Oxycodone for pain in fibromyalgia in adults. This review replaces part of an earlier review that evaluated oxycodone for both neuropathic pain and fibromyalgia, which has now been split into separate reviews for the two conditions. This review will consider pain in fibromyalgia only.Opioid drugs are commonly used to treat fibromyalgia, but they may not be beneficial for people with this condition. Most reviews have examined all opioids together. This review sought evidence specifically (...) for oxycodone, at any dose, and by any route of administration.To assess the analgesic efficacy and adverse events of oxycodone for treating pain in fibromyalgia in adults.We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE for randomised controlled trials from inception to 25 July 2016. We also searched the reference lists of retrieved studies and reviews, and searched online clinical trial registries.We planned to include randomised, double-blind trials of eight

2016 Cochrane

123. Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases Full Text available with Trip Pro

Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases To evaluate the performance of the Fibromyalgia Rapid Screening Tool (FiRST) self-questionnaire for the detection of FM associated with inflammatory rheumatic diseases.This cross-sectional, French single-centre study was carried out between September 2014 and April 2015 in all patients who consulted for RA, SpA or CTD. Diagnosis of FM was based on ACR 90 criteria and rheumatologist

2016 EvidenceUpdates

124. The Fibromyalgia Survey Score Correlates With Preoperative Pain Phenotypes But Does Not Predict Pain Outcomes After Shoulder Arthroscopy Full Text available with Trip Pro

The Fibromyalgia Survey Score Correlates With Preoperative Pain Phenotypes But Does Not Predict Pain Outcomes After Shoulder Arthroscopy Fibromyalgia (FM) characteristics can be evaluated using a simple, self-reported measure that correlates with postoperative opioid consumption after lower-extremity joint arthroplasty. The purpose of this study was to determine whether preoperative pain history and the FM survey score can predict postoperative outcomes after shoulder arthroscopy, which may (...) score), and day 14 (opioid consumption, pain).FM survey scores ranged from 0 to 13. The cohort was divided into tertiles for univariate analyses. Preoperative depression and anxiety (P<0.001) and neuropathic pain (P=0.008) were higher, and physical functioning was lower (P<0.001), in higher FM survey score groups. The fibromyalgia survey score was not associated with postoperative pain or opioid consumption; however, it was independently associated with poorer quality of recovery scores (P=0.001

2016 EvidenceUpdates

125. EULAR revised recommendations for the management of fibromyalgia Full Text available with Trip Pro

EULAR revised recommendations for the management of fibromyalgia The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were 'expert opinion'.A multidisciplinary group from 12 countries assessed evidence with a focus on systematic reviews and meta-analyses concerned with pharmacological/non-pharmacological management for fibromyalgia. A review, in May 2015, identified eligible

2016 EvidenceUpdates

126. Cannabinoids for fibromyalgia. Full Text available with Trip Pro

Cannabinoids for fibromyalgia. This review is one of a series on drugs used to treat fibromyalgia. Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue affecting approximately 2% of the general population. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses on reducing key symptoms and disability, and improving (...) HRQoL. Cannabis has been used for millennia to reduce pain and other somatic and psychological symptoms.To assess the efficacy, tolerability and safety of cannabinoids for fibromyalgia symptoms in adults.We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE to April 2016, together with reference lists of retrieved papers and reviews, three clinical trial registries, and contact with trial authors.We selected randomised controlled trials of at least four weeks

2016 Cochrane

127. Perspectives on Living With Fibromyalgia Full Text available with Trip Pro

Perspectives on Living With Fibromyalgia Perceptions of people living with chronic illness change over time, contributing to health-related stress that necessitates coping skills. Paterson's shifting perspectives model provides an explanation of chronically ill people's variations in attention to their symptoms. In this qualitative study, 20 people with fibromyalgia living in a rural setting were interviewed in 2013 with the aim of gaining insight into their experiences and the meaning-making (...) providers in understanding those diagnosed with fibromyalgia and their care needs.

2016 Global qualitative nursing research

128. Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia (Abstract)

Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia Fibromyalgia (FM) is a chronic pain disorder for which pregabalin is an approved treatment in the United States. Although opioids are not a recommended treatment option, they continue to be used by many FM patients. The impact of patients' prior opioid use on their subsequent response to pregabalin has not been assessed.This was a pooled analysis of 4 clinical trials to assess the efficacy of pregabalin

2016 EvidenceUpdates Controlled trial quality: uncertain

129. Antipsychotics for fibromyalgia in adults. Full Text available with Trip Pro

Antipsychotics for fibromyalgia in adults. This review is one of a series on drugs used to treat fibromyalgia. Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. It affects approximately 2% of the general population. Up to 70% of patients with fibromyalgia meet the criteria for a depressive or anxiety disorder. People often report high disability levels and poor health (...) -related quality of life. Drug therapy focuses on reducing key symptoms and disability, and improving health-related quality of life. Antipsychotics might reduce fibromyalgia and associated mental health symptoms.To assess the efficacy, tolerability and safety of antipsychotics in fibromyalgia in adults.We searched CENTRAL (2016, Issue 4), MEDLINE and EMBASE to 20 May 2016, together with reference lists of retrieved papers and reviews and two clinical trial registries. We also contacted trial

2016 Cochrane

130. A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia Full Text available with Trip Pro

A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia Current therapeutic approaches to fibromyalgia syndrome (FMS) do not provide satisfactory pain control to a high percentage of patients. This unmet need constantly fuels the pursuit for new modalities for pain relief. This randomised, double-blind, controlled study assessed the efficacy and safety of adding etoricoxib vs. placebo to the current therapeutic regimen of female patients (...) with FMS.In this double-blind, placebo-controlled study, female patients were randomised to receive either 90 mg etoricoxib once daily or placebo for 6 weeks. Several physical and mental parameters were assessed throughout the study. The primary end-point was the response to treatment, defined as ≥ 30% reduction in the average Brief Pain Inventory score. Secondary outcomes were changes in the Fibromyalgia Impact Questionnaire, SF-36 Quality of Life assessment questionnaire and Hamilton rating scales

2016 EvidenceUpdates Controlled trial quality: predicted high

131. Yoga as an Effective Therapy to Reduce Symptoms in Patients with Fibromyalgia

Yoga as an Effective Therapy to Reduce Symptoms in Patients with Fibromyalgia "Yoga as an Effective Therapy to Reduce Symptoms in Patients with Fibro" by Rachel K. Johnson < > > > > > Title Author Date of Graduation Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Anjanette Sommers, PA-C Rights . Abstract Background: Fibromyalgia is a debilitating chronic disease characterized by musculoskeletal pain, fatigue (...) , and compromises in cognition. One of the biggest challenges surrounding fibromyalgia is proper diagnosis, as there is no current diagnostic test established. Most practitioners utilize examining tender points and other subjective self-assessments to aid in the assessment of the condition. Current therapies include both medication and non-pharmacologic such as chiropractic therapy, acupuncture, aerobic exercise, and yoga. Yoga is an ancient Indian practice incorporating physical poses, deep breathing, self

2016 Pacific University EBM Capstone Project

132. Hormonal responses to aerobic exercise in woman with fibromyalgia: systematic review and meta-analysis

Hormonal responses to aerobic exercise in woman with fibromyalgia: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2016 PROSPERO

133. Effectiveness of hormonal treatments for fibromyalgia: a systematic review

Effectiveness of hormonal treatments for fibromyalgia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2016 PROSPERO

134. Strength training for the treatment of fibromyalgia syndrome: systematic review and methodological analysis of results

Strength training for the treatment of fibromyalgia syndrome: systematic review and methodological analysis of results Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

135. Evidence of spirituality/religiosity in symptoms of fibromyalgia: a systematic review

Evidence of spirituality/religiosity in symptoms of fibromyalgia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

136. Hypnosis and guided imagery for fibromyalgia

Hypnosis and guided imagery for fibromyalgia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect

2016 PROSPERO

137. Effect of co-enzyme Q10 supplementation on clinical symptoms of fibromyalgia patients: a systematic review and meta-analysis of randomized controlled trials

Effect of co-enzyme Q10 supplementation on clinical symptoms of fibromyalgia patients: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2016 PROSPERO

138. Association between fibromyalgia and suicidal ideation: a systematic review and meta-analysis

Association between fibromyalgia and suicidal ideation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO

139. Mitochondrial dysfunction in fibromyalgia: aerobic and anaerobic imbalance

Mitochondrial dysfunction in fibromyalgia: aerobic and anaerobic imbalance Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2016 PROSPERO

140. Transcutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia in adults [Cochrane Protocol]

Transcutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia in adults [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO